BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3571382)

  • 1. Characterization of fat-induced neurotensin-like immunoreactivity in plasma using column liquid chromatography and radioimmunoassay.
    Draviam EJ; Greeley GH; Lluis F; Uchida T; Trowbridge J; Thompson JC
    J Chromatogr; 1987 Feb; 414(1):180-6. PubMed ID: 3571382
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion.
    Theodorsson-Norheim E; Rosell S
    Regul Pept; 1983 Jul; 6(3):207-18. PubMed ID: 6622752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neurotensin in the conscious pig: release by individual food components and effects on exocrine pancreas secretion.
    Cuber JC; Philippe C; Abello J; Corring T; Levenez F; Chayvialle JA
    Pancreas; 1990 May; 5(3):306-13. PubMed ID: 2343043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography.
    Draviam EJ; Upp JR; Greeley GH; Townsend CM; Thompson JC
    Dig Dis Sci; 1990 Feb; 35(2):200-4. PubMed ID: 2302977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatographic characterisation of neurotensin-like immunoreactivity in plasma and tissue extracts from hepatoma patients.
    Lee YC; Bacarese-Hamilton AJ; Wood SM; Blumgart LH; Bloom SR
    Clin Chim Acta; 1985 Jun; 149(1):29-36. PubMed ID: 2992844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for neurotensin.
    Kronheim S; Sheppard MC; Miller J
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):159-64. PubMed ID: 7261413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal failure or portacaval shunt on release of neurotensin in man.
    Eaves ER; Hansky J
    Dig Dis Sci; 1987 Jan; 32(1):28-32. PubMed ID: 3792180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro degradation of neurotensin in human plasma.
    Lee YC; Uttenthal LO; Smith HA; Bloom SR
    Peptides; 1986; 7(3):383-7. PubMed ID: 3774585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man.
    Rosell S; Rökaeus A
    Acta Physiol Scand; 1979 Nov; 107(3):263-67. PubMed ID: 539456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radioimmunoassay for neurotensin in human plasma.
    Blackburn AM; Bloom SR
    J Endocrinol; 1979 Nov; 83(2):175-81. PubMed ID: 574894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the ileum in neurotensin released by fat.
    Walker JP; Fujimura M; Sakamoto T; Greeley GH; Townsend CM; Thompson JC
    Surgery; 1985 Aug; 98(2):224-9. PubMed ID: 4023920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal.
    Lee YC; Allen JM; Uttenthal LO; Roberts PM; Gill SS; Bloom SR
    Dig Dis Sci; 1985 Feb; 30(2):129-33. PubMed ID: 3838153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nephrectomy and ureter ligation on plasma neurotensin-like immunoreactivity levels in the conscious rat.
    Theodorsson-Norheim E; Al-Saffar A; Saria A; Rosell S
    Acta Physiol Scand; 1985 Mar; 123(3):269-72. PubMed ID: 4061110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
    Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
    J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute exercise on plasma neurotensin levels.
    Peachey SE; Skrinar GS; Leeman SE; Pehrson J; Evans WJ; Bullen BA
    Peptides; 1989; 10(4):753-6. PubMed ID: 2587418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meal-stimulated neurotensin immunoreactivity in plasma following gastric surgery: characterisation with two region-specific antisera.
    Shaw C; Watt PC; Buchanan KD
    Digestion; 1986; 33(3):152-60. PubMed ID: 2419192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components.
    Hammer RA; Carraway RE; Leeman SE
    J Clin Invest; 1982 Jul; 70(1):74-81. PubMed ID: 7085889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma radioimmunoassayable neurotensin responses to the administration of various nutrients.
    Ito S; Matsubara Y; Sihibata A
    Tohoku J Exp Med; 1982 Jan; 136(1):109-10. PubMed ID: 7071824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations.
    Carraway RE; Mitra SP; Ferris CF
    Endocrinology; 1986 Oct; 119(4):1519-26. PubMed ID: 2428598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.